PER 5.26% 8.0¢ percheron therapeutics limited

Ann: Plasma protein data supports bone density improvement in DMD, page-3

  1. 265 Posts.
    lightbulb Created with Sketch. 499
    Significant modulation of two bone morphogenetic proteins supports potential of ATL1102 for improving bone density in DMD
    Statistically significant mean increases in plasma BMP-5 and BMP-6 with a role in cartilage and bone formation
    • Increases in mean plasma BMP-5 and BMP-6 to external healthy adult control levels are supportive of ATL1102’s potential to promote bone regeneration and improve bone density in DMD
    • New proteomics data compliments previously presented data on ATL1102’s unique and highly relevant mechanism as a potential DMD treatment

    Here we go.... Huge market...

    Increases in mean plasma BMP-5 and BMP-6 to external healthy adult control levels are supportive of ATL1102’s potential to promote bone regeneration and improve bone density in DMD

    Stay tuned for more good news....indications etc..
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.004(5.26%)
Mkt cap ! $72.12M
Open High Low Value Volume
7.9¢ 8.0¢ 7.7¢ $35.48K 451.2K

Buyers (Bids)

No. Vol. Price($)
1 12500 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 198147 2
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.